Genscript Biotech Corp GNNSF
$3.86 $0.06 (1.58%) 1D
Last Updated: Aug 20, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
GNNSF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Genscript Biotech Corp is classified as halal.
HALAL
Report Source: undefined Quarter Report
Genscript Biotech Corp. Stock Analysis GNNSF
United States Health Care Mid Cap Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. The company employs 6,165 full-time employees The company went IPO on 2015-12-30. The firm operates its businesses through five segments. The Life-science Services and Products segment provides comprehensive research services and products. The Biologics Development Services segment provides comprehensive services to help biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene, cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment provides industrial enzyme development and production through non-pathogenic microbial strains constructed using genetic engineering. The Cell Therapy segment discovers and develops CAR-T therapies for the treatment of liquid and solid tumors. The Operation segment provides shared services to other segments. The firm mainly operates its businesses in the domestic and overseas markets.
Genscript Biotech Corp (GNNSF) Chart
Financial Metrics & Statements of Genscript Biotech Corp (GNNSF)
FAQ's for Genscript Biotech Corp (GNNSF)
- As of August 2026, Genscript Biotech Corp GNNSF is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Genscript Biotech Corp using these criteria to determine its compliance status.
- Muslim investors may consider investing in Genscript Biotech Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Genscript Biotech Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Genscript Biotech Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Genscript Biotech Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Genscript Biotech Corp (GNNSF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
